Vim Funding: $72M Raised, Series B (2021)

Vim funding overview

Vim is based in San Francisco. Vim has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for Vim runs through 2021; nothing later has been disclosed. Investors on record include Optum Ventures, Great Point Ventures, Sequoia Capital, Leverage Health Solutions, Walgreens, Anthem and 2 others. 8 distinct backers are named across the disclosed rounds.

Vim at a glance

Total raised: $72M
Latest round: Series B
Latest round date: May 2021
Headquarters: San Francisco
Notable investors: Optum Ventures, Great Point Ventures, Sequoia Capital, Leverage Health Solutions, Walgreens, Anthem, Frist Cressey Ventures, Premera Blue Cross

Frequently asked about Vim funding

How much has Vim raised?: Vim has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Vim?: Optum Ventures, Great Point Ventures, Sequoia Capital, Leverage Health Solutions, Walgreens, Anthem are named among the investors backing Vim.
What was the latest Vim funding round?: The most recent disclosed round is a Series B, announced in May 2021.
Where is Vim based?: Vim is based in San Francisco.
When did Vim last raise?: The last disclosed Vim round closed in May 2021 at Series B.

Every Vim figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.

Vim Funding: $72M Raised, Series B (2021)

Vim funding overview

Vim at a glance

Frequently asked about Vim funding

Companies related to Vim (35)

Browse related funding lists (7)